<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0138-600X</journal-id>
<journal-title><![CDATA[Revista Cubana de Obstetricia y Ginecología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Obstet Ginecol]]></abbrev-journal-title>
<issn>0138-600X</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0138-600X2011000400003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Fallo renal agudo en la paciente obstétrica gravemente enferma]]></article-title>
<article-title xml:lang="en"><![CDATA[Acute renal failure in the severely ill obstetric patient]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Valdivia]]></surname>
<given-names><![CDATA[Alfredo Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Padrón]]></surname>
<given-names><![CDATA[Alfredo Julián]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Somoza García]]></surname>
<given-names><![CDATA[Manuel Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González Cobo]]></surname>
<given-names><![CDATA[Silvia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Guerra]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hospital Universitario Faustino Pérez  ]]></institution>
<addr-line><![CDATA[Matanzas ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2011</year>
</pub-date>
<volume>37</volume>
<numero>4</numero>
<fpage>457</fpage>
<lpage>470</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0138-600X2011000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0138-600X2011000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0138-600X2011000400003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Introducción: el fracaso renal agudo en el embarazo puede ser inducido por las mismas causas que afectan a la población general, sin embargo existen complicaciones de cada trimestre del embarazo que pueden resultar en fallo renal. Objetivo: reconocer las principales características clínicas y terapéuticas de la insuficiencia renal aguda en la obstétrica grave. Métodos: se realizó la caracterización clínica del fallo renal agudo en la obstétrica gravemente enferma en la sala de cuidados intensivos, a través de un estudio observacional transversal durante 2 años, sobre 12 pacientes portadoras, de un total de 96 obstétricas graves que ingresaron en la unidad. Resultados: el 12, 5 % de las pacientes ingresadas desarrollaron esta entidad con mortalidad del 16,6 %. La causa más frecuente de fallo renal agudo fue la enfermedad hipertensiva del embarazo y predominó el fallo parenquimatoso (necrosis tubular aguda). Se emplearon métodos depuradores en 7 pacientes (58,3 %) y predominó la hemodiafiltración continua entre las técnicas empleadas aunque el tratamiento médico fue importante. El fallo renal agudo se asoció a la disfunción/fracaso multiorgánico en el 83,3 % con mortalidad del 20 %. Conclusión: la paciente obstétrica es una población de alto riesgo para el desarrollo del fallo renal.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Introduction: the acute renal failure during pregnancy may be induced by the same causes affecting to the general population, however, there are complications of each trimester of pregnancy that may become a renal failure. Objective: to recognize the main clinical features in the severe obstetric patient. Methods: a clinical characterization of acute renal failure was made in the severely ill obstetric patient admitted in the intensive care unit (ICU) by means of a cross-sectional and observational study over two years in 12 carrier patients from a total of 96 severe obstetric patients admitted in that unit. Results: the 12.5 % of patients admitted developed this entity for a mortality of 16.6 %. The more frequent cause of acute renal failure was the hypertensive disease of obstetric with predominance of parenchymatous failure (acute tubular necrosis). Authors used depurative methods in 7 patients (58.3 %) with predominance of a continuous hemofiltration among the techniques used although the medical treatment was important. The acute renal failure was associated with the dysfunction/multi-organ failure in the 83.3 % for a mortality of 20 %. Conclusion: The obstetric patient is a group with high risk for development of renal failure.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[paciente obstétrica gravemente enferma]]></kwd>
<kwd lng="es"><![CDATA[fallo renal agudo]]></kwd>
<kwd lng="es"><![CDATA[mortalidad materna]]></kwd>
<kwd lng="es"><![CDATA[insuficiencia renal aguda]]></kwd>
<kwd lng="en"><![CDATA[Severely ill obstetric patient]]></kwd>
<kwd lng="en"><![CDATA[acute renal failure]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana" size="2"> <B>OBSTETRICIA </B></font></p>     <p><B> </B></p> <B>     <P>      <P>      <P><font face="Verdana" size="4">Fallo renal agudo en la paciente obst&eacute;trica    gravemente enferma</font>     <P> </B>      <P><font face="Verdana" size="3"><b>Acute renal failure in the severely ill obstetric    patient</b></font>     <P>     <P>     <P>      ]]></body>
<body><![CDATA[<P>      <P>     <p><font face="Verdana" size="2"><B>Dr. Alfredo Jorge S&aacute;nchez Valdivia,    Dr. Alfredo Juli&aacute;n S&aacute;nchez Padr&oacute;n, Dr. Manuel Ernesto Somoza    Garc&iacute;a, Dra. Silvia Gonz&aacute;lez Cobo, Dr. Carlos L&oacute;pez Guerra</B></font></p>     <p><font face="Verdana" size="2">Hospital Universitario &quot;Faustino P&eacute;rez&quot;.    </font><font face="Verdana" size="2">Matanzas, Cuba.</font></p>     <p>&nbsp;</p> <hr size="1" noshade> <B> </B><B>     <P>      <P>      <P><font face="Verdana" size="2">RESUMEN </font> </B>      <P><font face="Verdana" size="2"><B>Introducci&oacute;n:</b> el fracaso renal    agudo en el embarazo puede ser inducido por las mismas causas que afectan a    la poblaci&oacute;n general, sin embargo existen complicaciones de cada trimestre    del embarazo que pueden resultar en fallo renal.    <br>   </font><font face="Verdana" size="2"><B>Objetivo:</B> reconocer las principales    caracter&iacute;sticas cl&iacute;nicas y terap&eacute;uticas de la insuficiencia    renal aguda en la obst&eacute;trica grave. <B>    ]]></body>
<body><![CDATA[<br>   M&eacute;todos: </B>se realiz&oacute; la caracterizaci&oacute;n cl&iacute;nica    del fallo renal agudo en la obst&eacute;trica gravemente enferma en la sala    de cuidados intensivos, a trav&eacute;s de un estudio observacional transversal    durante 2 a&ntilde;os, sobre 12 pacientes portadoras, de un total de 96 obst&eacute;tricas    graves que ingresaron en la unidad.     <br>   </font><font face="Verdana" size="2"><B>Resultados: </B>el 12, 5 % de las pacientes    ingresadas desarrollaron esta entidad con mortalidad del 16,6 %. La causa m&aacute;s    frecuente de fallo renal agudo fue la enfermedad hipertensiva del embarazo y    predomin&oacute; el fallo parenquimatoso (necrosis tubular aguda). Se emplearon    m&eacute;todos depuradores en 7 pacientes (58,3 %) y predomin&oacute; la hemodiafiltraci&oacute;n    continua entre las t&eacute;cnicas empleadas aunque el tratamiento m&eacute;dico    fue importante. El fallo renal agudo se asoci&oacute; a la disfunci&oacute;n/fracaso    multiorg&aacute;nico en el 83,3 % con mortalidad del 20 %.    <br>   </font><font face="Verdana" size="2"><B>Conclusi&oacute;n:</B> la paciente obst&eacute;trica    es una poblaci&oacute;n de alto riesgo para el desarrollo del fallo renal. </font>      <P>      <P><font face="Verdana" size="2"><B>Palabras clave</B>: paciente obst&eacute;trica    gravemente enferma, fallo renal agudo, mortalidad materna, insuficiencia renal    aguda. </font> <hr size="1" noshade>     <P> <font face="Verdana" size="2"><B>ABSTRACT     <br>     <br> </B></font><B>      <P>  </B>      <P><font face="Verdana" size="2"><B>Introduction: </b>the acute renal failure    during pregnancy may be induced by the same causes affecting to the general    population, however, there are complications of each trimester of pregnancy    that may become a renal failure. </font>     ]]></body>
<body><![CDATA[<br>   <font face="Verdana" size="2"><B>Objective: </B>to recognize the main clinical    features in the severe obstetric patient.    <br>   </font><font face="Verdana" size="2"><B>Methods</B>: a clinical characterization    of acute renal failure was made in the severely ill obstetric patient admitted    in the intensive care unit (ICU) by means of a cross-sectional and observational    study over two years in 12 carrier patients from a total of 96 severe obstetric    patients admitted in that unit.     <br>   </font><font face="Verdana" size="2"><B>Results</B>: the 12.5 % of patients    admitted developed this entity for a mortality of 16.6 %. The more frequent    cause of acute renal failure was the hypertensive disease of obstetric with    predominance of parenchymatous failure (acute tubular necrosis). Authors used    depurative methods in 7 patients (58.3 %) with predominance of a continuous    hemofiltration among the techniques used although the medical treatment was    important. The acute renal failure was associated with the dysfunction/multi-organ    failure in the 83.3 % for a mortality of 20 %.     <br>   </font><font face="Verdana" size="2"><B>Conclusion</B>: The obstetric patient    is a group with high risk for development of renal failure. </font>      <P>      <P><font face="Verdana" size="2"><B>Key words</B>: Severely ill obstetric patient,    acute renal failure. </font> <hr size="1" noshade>     <p>&nbsp;</p>    <P>     <P>      <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="3"><B>INTRODUCCI&Oacute;N</B> </font>     <P>      <P><font face="Verdana" size="2">La presencia de fallo o insuficiencia renal aguda    (IRA) asociado a la gestaci&oacute;n ha disminuido en los &uacute;ltimos 30    a&ntilde;os. <I>Nzerue</I> y otros identificaron 21 casos de fallo renal agudo    en el embarazo en el Hospital Grady Memorial en un per&iacute;odo de 10 a&ntilde;os    (1986-1996) con una incidencia de 2 x 10 000 partos.<SUP>1 </SUP> </font>     <P>      <P><font face="Verdana" size="2">El fracaso renal agudo en el embarazo puede ser    inducido por las mismas causas que afectan a la poblaci&oacute;n general, sin    embargo existen complicaciones de cada trimestre del embarazo que pueden resultar    en fallo renal. En el primer trimestre predominan las causas prerrenales debidas    a hiperemesis grav&iacute;dica y m&aacute;s tarde el aborto s&eacute;ptico.    En gestaciones avanzadas la enfermedad hipertensiva del embarazo, los trastornos    hemorr&aacute;gicos del embarazo, parto o puerperio, as&iacute; como la sepsis    se convierten en injurias protag&oacute;nicas para la instauraci&oacute;n del    fallo renal.<SUP>2</SUP> </font>      <P>      <P><font face="Verdana" size="2">El fallo renal agudo es un s&iacute;ndrome que    rara vez se desarrolla en la comunidad, su presentaci&oacute;n es esencialmente    hospitalaria y complica el curso de aproximadamente el 5 % de los pacientes    hospitalizados.<SUP>3</SUP> Los pacientes cr&iacute;ticos tienen la mayor incidencia    de fallo renal agudo mayor del 20 %.<SUP>4</SUP> </font>     <P>      <P><font face="Verdana" size="2">Se define el fallo renal agudo desde el punto    de vista del laboratorio cl&iacute;nico como el incremento de la creatinina    s&eacute;rica (CS) con valor menor a 0,5 mg/dl (44,2 mmol/l) si la creatinina    s&eacute;rica basal (CSB) es menor de 2,5 mg/dl (221 mmol/l) o un incremento    de la creatinina de m&aacute;s del 20 % si la CSB es mayor de 2,5 mg/dl (221    mmol/l) en un tiempo de 2 sem.<SUP>5</SUP> Se propone recientemente como criterio    diagn&oacute;stico de IRA al s&iacute;ndrome cl&iacute;nico resultante de un    deterioro brusco de la funci&oacute;n renal (&lt; 48 h) con incremento absoluto    de la CS mayor o igual a 0,3 mg/dl (26,4 mmol/l) o un incremento de la CS mayor    o igual al 50 %; o un incremento de 1,5 veces el valor basal o una reducci&oacute;n    del gasto urinario (GU) menor de 0,5 ml/kg/h por m&aacute;s de 6 h.<SUP>6</SUP><B><FONT  COLOR="#ff0000"> </FONT></B> </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Cuando la IRA aparece en el curso de un fallo    multiorg&aacute;nico sobre todo en pacientes con hipotensi&oacute;n severa o    distr&eacute;s respiratorio la mortalidad oscila entre un 50-80 %.<SUP>7</SUP>    </font>      <P>      <P><font face="Verdana" size="2">En el tratamiento de pacientes obst&eacute;tricas    gravemente enfermas, por m&aacute;s de 20 a&ntilde;os los autores han observado    que los &oacute;rganos m&aacute;s afectados por las complicaciones surgidas    en el embarazo, parto o puerperio son pulmones y ri&ntilde;ones. Ellos han detectado    una incidencia alta de fracaso respiratorio en pacientes obst&eacute;tricas    (1/1172 partos);<SUP>8,9</SUP> sin embargo no existen estudios en la literatura    nacional revisada que describan el comportamiento de la injuria renal en la    paciente obst&eacute;trica gravemente enferma.    <br>   </font><font color="#0000FF">    <br>   </font>      <P>      <P><font face="Verdana" size="2" color="#000000">En esta invetigaci&oacute;n como    objetivos espec&iacute;ficos se plantearon, identificar las principales causas    de insuficiencia renal aguda en la obst&eacute;trica grave, reconocer las complicaciones    asociadas al fallo renal agudo en la obst&eacute;trica grave, caracterizar el    tipo cl&iacute;nico de fallo renal agudo en la paciente obst&eacute;trica grave,    valorar las modalidades terap&eacute;uticas usadas en la obst&eacute;trica grave    con fallo renal y la metodolog&iacute;a.</font><font face="Verdana" size="2" color="#0000FF">    </font>      <P>      <P>      <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="3"><B>M&Eacute;TODOS</B> </font>     <P>      <P><font face="Verdana" size="2">Se trata de un estudio observacional transversal,    descriptivo, de campo y no experimental. </font>      <P>      <P><font face="Verdana" size="2">Universo (N): Pacientes obst&eacute;tricas gravemente    enfermas ingresadas por cualquier entidad en la unidad de cuidados intensivos.<B>    </B> </font>     <P><font face="Verdana" size="2">Muestra (n): Pacientes obst&eacute;tricas gravemente    enfermas que desarrollaron fallo renal agudo ingresadas en cuidados intensivos.    </font>     <P>      <P><font face="Verdana" size="2">Se incluyeron todas las pacientes obst&eacute;tricas    (consider&aacute;ndose como tal aquella mujer embarazada o dentro de los 42    d&iacute;as siguientes al fin del embarazo) que desarrollaron fallo renal agudo.    Se defini&oacute; el fallo renal agudo seg&uacute;n los criterios mencionados    anteriormente en este trabajo.<SUP>5,6</SUP> </font>      <P>      <P><font face="Verdana" size="2">&Aacute;mbito: Terapia Intensiva Polivalente    (UCI<SUB>p</SUB>) del Hospital Universitario &quot;Comandante Faustino P&eacute;rez&quot;    de la provincia de Matanzas. </font>      ]]></body>
<body><![CDATA[<P>      <P><font face="Verdana" size="2">Fecha de realizaci&oacute;n: abarc&oacute; desde    el 1ro.de enero de 2006 hasta el 31 de diciembre de 2007.7</font>      <P>      <P><font face="Verdana" size="2">La obtenci&oacute;n de los datos de inter&eacute;s    para el cumplimiento de los objetivos se realiz&oacute; mediante la aplicaci&oacute;n    de una encuesta (<a href="#ane1">anexo 1</a>). Esta encuesta se aplic&oacute;    a todas las pacientes obst&eacute;tricas gravemente enfermas que ingresaron    en la referida unidad por cualquier causa<B><FONT  COLOR="#ff0000"> </FONT></B>previo consentimiento informado a la paciente o a    sus familiares en casos de toma de conciencia. </font>      <P>    <br>     <P>      <P><font face="Verdana" size="2">Las variables tenidas en cuenta para la caracterizaci&oacute;n    de la muestra fueron: </font>     <P><font face="Verdana" size="2">- Obst&eacute;tricas con fallo renal agudo (variable    de pacientes obst&eacute;tricas gravemente enfermas que desarrollaron insuficiencia    renal aguda). Variable cuantitativa discreta.     <br>   </font><font face="Verdana" size="2">- Etiolog&iacute;a del fracaso renal agudo    (variable num&eacute;rica y porcentual de las causas del fallo renal agudo).    Variable cualitativa nominal polit&oacute;mica.     ]]></body>
<body><![CDATA[<br>   </font><font face="Verdana" size="2">- Tipo de fallo renal agudo (variable num&eacute;rica    y porcentual del tipo cl&iacute;nico de fallo renal agudo). Variable cualitativa    nominal polit&oacute;mica.     <br>   </font><font face="Verdana" size="2">- Procederes terap&eacute;uticos (variable    de procederes terap&eacute;uticos realizados por personal de cuidados intensivos).    Variable cualitativa nominal &nbsp;&nbsp;polit&oacute;mica.     <br>   </font><font face="Verdana" size="2">- Relaci&oacute;n con el fracaso de otros    &oacute;rganos o sistemas (variable num&eacute;rica de la relaci&oacute;n con    la disfunci&oacute;n/fallo de otros &oacute;rganos y sistemas que presentaron    las pacientes obst&eacute;tricas gravemente enfermas con fallo renal agudo).    Variable cualitativa nominal polit&oacute;mica. </font>      <P><font face="Verdana" size="2">En el caso de las fallecidas se verificaron los    protocolos de necropsia para hacer la correlaci&oacute;n cl&iacute;nico-patol&oacute;gica    y obtener las causas de muerte. </font>      <P>      <P><font face="Verdana" size="2">Para la recogida de la informaci&oacute;n se    aplic&oacute; una encuesta (<a href="#ane1">anexo 1</a>) con las variables de    inter&eacute;s propuestas y para conocer el grado de disfunci&oacute;n/fallo    org&aacute;nico se aplicaron los criterios recogidos en el <a href="#ane2">anexo    2</a>. El procesamiento de los datos fue mediante el software estad&iacute;stico    SPSS-10 para Windows. Textos y tablas procesadas con MS Word 2007. Las t&eacute;cnicas    estad&iacute;sticas empleadas fueron el an&aacute;lisis de frecuencia y porcentual.    Los resultados de la investigaci&oacute;n fueron plasmados en tablas. </font>      <P>     <P>      <P>      <P>      ]]></body>
<body><![CDATA[<P>      <P>      <P><font face="Verdana" size="3"><B>RESULTADOS</B> </font>     <P>      <P><font face="Verdana" size="2">En los 2 a&ntilde;os estudiados de las 96 obst&eacute;tricas    ingresadas desarrollaron fallo renal agudo 12 (12,5 %); de ellas resultaron    vivas 10 (10,4 %) mientras que fallecieron 2 (2 %) seg&uacute;n la <a href="#tab1">tabla    1</a>. </font>      <P align="center"><img src="/img/revistas/gin/v37n4/t0103411.gif" width="544" height="171"> <a name="tab1"></a>     
<P><font face="Verdana" size="2">La enfermedad hipertensiva del embarazo fue la    causa m&aacute;s frecuente (5/12/ 41,6 %) con una fallecida que desarroll&oacute;    un s&iacute;ndrome de Hellp; el choque s&eacute;ptico tuvo solo 2 casos/16,6    % sin decesos y otras causas fueron menos frecuentes (<a href="#tab2">tabla    2</a>). </font>      <P align="center"><font face="Verdana" size="2"><img src="/img/revistas/gin/v37n4/t0203411.gif" width="481" height="308">    <a name="tab2"></a> </font>      
<P>      <P><font face="Verdana" size="2">El tipo cl&iacute;nico de fracaso renal m&aacute;s    frecuente estuvo relacionado con el fallo parenquimatoso (9/12/ 75 %) en las    2 fallecidas del estudio. A pesar de ser una serie peque&ntilde;a hubo 2 obst&eacute;tricas    con fracaso posrrenal (obstructivo extraluminal en las 2 pacientes) (<a href="#t3">tabla    3</a>). </font>     ]]></body>
<body><![CDATA[<P align="center"><img src="/img/revistas/gin/v37n4/t0303411.gif" width="369" height="232"><a name="t3"></a>      
<P align="center">     <P><font face="Verdana" size="2">Se usaron m&eacute;todos depuradores extrarrenales    en 7 obst&eacute;tricas (58,3 %); depuradores lentos o continuos en 4 pacientes    (3 veno-venoso y 1 arterio-venoso) mientras la hemodi&aacute;lisis/ultrafiltraci&oacute;n    intermitente diaria de uso precoz se emple&oacute; en 3 pacientes. La plasmaf&eacute;resis    se us&oacute; en 2 pacientes en sesiones diarias con recambio de 1,5 litros    en una paciente portadora de s&iacute;ndrome de Hellp y otra con una atrofia    amarilla hep&aacute;tica. En las 5 (41,6 %) obst&eacute;tricas restantes se    us&oacute; tratamiento m&eacute;dico sin fallecidas (<a href="#tab4">tabla 4</a>).    </font>      <P align="center"><img src="/img/revistas/gin/v37n4/t0403411.gif" width="538" height="233"> <a name="tab4"></a>     
<P><font face="Verdana" size="2">No hubo relaci&oacute;n del fallo renal con la    disfunci&oacute;n/fracaso de otros &oacute;rganos o sistemas (Sdmo/Fmo) en 2    obst&eacute;tricas (16,6 %) y s&iacute; en 10 (83,3 %) con 2 fallecidas (20    %). La disfunci&oacute;n o fallo asociado m&aacute;s frecuente a la disfunci&oacute;n/fallo    renal fue el respiratorio y cardiovascular (7 pacientes), seguidos por la disfunci&oacute;n/fallo    de la coagulaci&oacute;n en 5 pacientes de los 10 con fallo multiorg&aacute;nico    seg&uacute;n la <a href="/img/revistas/gin/v37n4/t0503411.gif">tabla 5</a>. </font>      
<P>     <p><B> </B></p> <B>      <P>    <br>     <P><font face="Verdana" size="3">DISCUSI&Oacute;N</font>  </B>      ]]></body>
<body><![CDATA[<P>      <P><font face="Verdana" size="2"> Al analizar a las pacientes obst&eacute;tricas    gravemente enfermas complicadas con fallo renal agudo en el per&iacute;odo 1989-2000    se aprecia esta entidad en 35 pacientes (11,5 %) de las que fallecen 19 para    el 54,2 % de mortalidad. Se se&ntilde;ala como principales factores predisponentes:    la sepsis (30 obst&eacute;tricas), la inestabilidad hemodin&aacute;mica (24),    la enfermedad hipertensiva del embarazo (13) y en 5 pacientes la nefrotoxicidad.<SUP>10</SUP>    </font>     <P>      <P><font face="Verdana" size="2">En este reporte 12 (12,5 %) obst&eacute;tricas    desarrollaron fallo renal agudo en terapia intensiva en dos a&ntilde;os. Algunos    autores reportan que el fallo renal agudo se presenta durante la evoluci&oacute;n    en las UCIp de adultos en el 24,7 % de los pacientes; o sea existi&oacute; la    mitad de la incidencia de IRA de la poblaci&oacute;n general adulta en la obst&eacute;trica    grave.<SUP>11 </SUP>La mortalidad fue del 16,6 % y las 2 obst&eacute;tricas    que fallecieron (enfermedad hipertensiva del embarazo y atrofia amarilla hep&aacute;tica)    murieron en fracaso multiorg&aacute;nico (3 y 6 sistemas u &oacute;rganos);    cifra similar al 16 % reportada por otros autores.<SUP>1</SUP> </font>      <P>      <P><font face="Verdana" size="2">La etiolog&iacute;a del fallo renal es un buen    predictor del pron&oacute;stico. Las causas en cuidados intensivos son m&uacute;ltiples,    generalmente es desencadenado por efecto combinado de varios insultos como hipotensi&oacute;n,    sepsis y exposici&oacute;n a t&oacute;xicos entre otros.<SUP>11</SUP> En la    mayor&iacute;a de casos de IRA se identifica la necrosis tubular aguda isqu&eacute;mica    como la causa m&aacute;s frecuente seguido en orden de frecuencia por la causa    prerrenal.<SUP>12</SUP> </font>     <P>      <P><font face="Verdana" size="2">La paciente obst&eacute;trica gravemente enferma    tiene alto riesgo de fallo renal por varias razones como: sufrir estados de    contracci&oacute;n de volumen (por trastornos hemorr&aacute;gicos relacionados    con el embarazo, parto o puerperio o por la contracci&oacute;n del espacio vascular    debido a enfermedad hipertensiva); estar sometida a m&uacute;ltiples tratamientos    nefrot&oacute;xicos; ser una paciente quir&uacute;rgica (muchas veces reintervenida);    padecer de entidades de importante gravedad y disfunci&oacute;n endotelial con    hem&oacute;lisis microangiop&aacute;tica como en la enfermedad hipertensiva    del embarazo. En este estudio la enfermedad hipertensiva del embarazo fue la    causa m&aacute;s frecuente de fracaso renal agudo similar a lo reportado en    la literatura.<SUP>1</SUP> </font>     <P><font face="Verdana" size="2">Las causas de fallo renal agudo son importantes    predictoras de mortalidad. Un insulto nefrot&oacute;xico &uacute;nico usualmente    tiene buen pron&oacute;stico mientras que el fracaso renal asociado a Sdmo/Fmo    est&aacute; asociado a un pron&oacute;stico pobre. Las causas en cuidados intensivos    resultan de insultos combinados como hipotensi&oacute;n, sepsis y exposici&oacute;n    a nefrot&oacute;xicos entre otros.<SUP>12</SUP> Algunos autores reportan que    alrededor del 69 % de los pacientes con fallo renal agudo desarrollan Sdmo/Fmo    y la presencia de este incrementa 3 veces la mortalidad que es cercana al 80-90    %.<SUP>11,13</SUP> En este reporte las pacientes obst&eacute;tricas graves desarrollaron    Sdmo/Fmo asociado al fallo renal en el 83,3 % con mortalidad del 20 %, algo    mayor en este subgrupo aunque inferior a la citada por la literatura revisada.    </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Los requerimientos de di&aacute;lisis tienen    una mortalidad del 50 al 70 %.<SUP>13</SUP> Los m&eacute;todos lentos o continuos    no reportan diferencias en la sobrevida al ser comparados con la hemodi&aacute;lisis    intermitente; no obstante el Grupo de Atenci&oacute;n a la Materna Grave en    Matanzas (GAMG) apreci&oacute; las bondades de los m&eacute;todos lentos sobre    la hemodi&aacute;lisis intermitente bas&aacute;ndose en la estabilidad hemodin&aacute;mica    que garantizaron los primeros, pues en esta serie 7 de 8 pacientes sometidos    a depuraci&oacute;n extrarrenal presentaban una hemodinamia francamente deteriorada.<SUP>14,15<B><FONT  COLOR="#ff0000"> </FONT></B></SUP> </font>      <P>      <P><font face="Verdana" size="2">Las indicaciones de la terapia espec&iacute;fica    a emplear ser&aacute;n las propuestas por <I>Murray</I> y otros.<SUP>15</SUP>    La decisi&oacute;n de qui&eacute;n debe escoger el m&eacute;todo y manejarlo    es controversial; en Australia los intensivistas asumen el fallo renal agudo    sin intervenci&oacute;n del nefr&oacute;logo; en Estados Unidos sucede lo contrario    mientras que en Europa existe una aproximaci&oacute;n combinada.<SUP>16</SUP>    En la UCI<SUB>p</SUB> del &quot;Faustino P&eacute;rez&quot; el fallo renal agudo    en la paciente obst&eacute;trica gravemente enferma se asume de forma conjunta    entre un nefr&oacute;logo y un equipo multidisciplinario todos del Grupo de    Atenci&oacute;n a la Materna Grave. </font>      <P>      <P><font face="Verdana" size="2">Los factores implicados en el desarrollo del    fallo renal y asociados a peor pron&oacute;stico no est&aacute;n bien definidos    por lo que se reclaman estudios para identificarlos; igual ocurre en las poblaciones    de pacientes obst&eacute;tricas graves.<SUP>11</SUP> La prevenci&oacute;n de    la necrosis tubular aguda es piedra angular en la disminuci&oacute;n de la morbimortalidad,<SUP>1<B><FONT COLOR="#ff0000">    </FONT></B></SUP> pero no es tratada en este reporte por no ser su objetivo.    </font>      <P>      <P><font face="Verdana" size="2">El fracaso renal agudo se present&oacute; en    12 (12,5 %) de las 96 obst&eacute;tricas ingresadas en UTI<SUB>p </SUB>durante    los 2 a&ntilde;os estudiados, fallecieron 2 (16,6 %) cifra similar a la literatura    revisada. La causa m&aacute;s frecuente fue la enfermedad hipertensiva del embarazo    y el tipo cl&iacute;nico de fallo renal la necrosis tubular aguda. No siempre    fue necesario un tratamiento depurador extrarrenal (7 - 58,3 %) pues un n&uacute;mero    importante de casos (5 - 41,6 %) evolucionaron bien solo con medidas m&eacute;dicas;    no obstante la hemodiafiltraci&oacute;n continua fue el m&eacute;todo m&aacute;s    socorrido por la frecuente inestabilidad hemodin&aacute;mica. La asociaci&oacute;n    del fallo renal agudo al fracaso multiorg&aacute;nico fue importante (10 casos/83,3    %) con mortalidad menor (20 %) a lo citado por la literatura. El fallo renal    es una complicaci&oacute;n potencialmente fatal y no rara en la paciente obst&eacute;trica    gravemente enferma que ingresa en cuidados intensivos, por lo que debe ser atendida    por un equipo multidisciplinario. </font>      <P>    <br>     <P><font face="Verdana" size="2"><B><a name="ane1"></a>Anexo 1</B> </font>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Encuesta a la materna cr&iacute;tica. </font>     <P><font face="Verdana" size="2">1. Nombre______________________________ </font>     <P><font face="Verdana" size="2">2. HC ___________________ </font>     <P><font face="Verdana" size="2">3. CI____________________ </font>     <P><font face="Verdana" size="2">4. Edad_______ </font>     <P><font face="Verdana" size="2">5. Direcci&oacute;n_________________________________________    </font>      <P><font face="Verdana" size="2">6. Edad_____ </font>     <P><font face="Verdana" size="2">7. Peso actual____ Ideal____ Predictivo____ </font>     <P><font face="Verdana" size="2"> 8. Talla_____ </font>     <P><font face="Verdana" size="2">9. Raza: Blanca____ Negra____ Amarilla____ </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">10. Motivo de remisi&oacute;n: _________________________    </font>     <P><font face="Verdana" size="2">11. Fecha de ingreso U.T.I_________ </font>     <P><font face="Verdana" size="2">12. Fecha de egreso U.T.I__________ </font>     <P><font face="Verdana" size="2">13. Estad&iacute;a___________ </font>     <P><font face="Verdana" size="2">14. Cuadro inicial_________________________ </font>     <P><font face="Verdana" size="2">15. Inicio de los s&iacute;ntomas_________ </font>     <P><font face="Verdana" size="2">16. Tiempo gestacional________ </font>     <P><font face="Verdana" size="2">17. G____ P____ A____ </font>     <P><font face="Verdana" size="2">18. Tipo de parto_____________ </font>     <P><font face="Verdana" size="2">19. Forma terminar embarazo_______ </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">20. Antecedentes patol&oacute;gicos personales:    </font>     <P><font face="Verdana" size="2">21. Rotura prematura de membranas: S&iacute;____    No____ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Tiempo antes    del parto _______ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Antibi&oacute;tico:    S&iacute;____ No____ &#191;Cu&aacute;l?___________________ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Dosis___________    </font>     <P><font face="Verdana" size="2">22. Abordaje venoso: Perif&eacute;rico_____Profundo____    M&uacute;ltiple____Arterial____ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Hecho en _________    </font>     <P><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Tiempo _________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Complicaci&oacute;n    _______ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Retiro por qu&eacute;________________________    </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">23. Intubaci&oacute;n endotraqueal: </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Hecho en____________    </font>     <P><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Tiempo______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Cambios____________    </font>     <P><font face="Verdana" size="2">24. Ventilaci&oacute;n mec&aacute;nica artificial.    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Hecho en_____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Tiempo_____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Fecha de inicio_____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Fecha final_____________    </font>     <P> <table border="1" align="center">   <tr>      <td width="546"><font face="Verdana" size="2">Caracteres    ]]></body>
<body><![CDATA[<br>           <br>       </font></td>     <td width="28"><font face="Verdana" size="2">1 </font></td>     <td width="25"><font face="Verdana" size="2">2 </font></td>     <td width="23"><font face="Verdana" size="2">3</font></td>     <td width="19"><font face="Verdana" size="2">4</font></td>     <td width="20"><font face="Verdana" size="2">5</font></td>     <td width="18"><font face="Verdana" size="2">6</font></td>     <td width="15"><font face="Verdana" size="2">7</font></td>     <td width="20"><font face="Verdana" size="2">8</font></td>     <td width="17"><font face="Verdana" size="2">9</font></td>     <td width="16"><font face="Verdana" size="2">10</font></td>     <td width="21"><font face="Verdana" size="2">11</font></td>     <td width="19"><font face="Verdana" size="2">12</font></td>     <td width="22"><font size="2" face="Verdana">13</font></td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">Ventilador    <br>           <br>           </font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>      ]]></body>
<body><![CDATA[    <td width="546"><font face="Verdana" size="2">Modalidad</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>          <td width="546"><font face="Verdana" size="2">Volumen tid&aacute;lico o corriente</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>     ]]></body>
<body><![CDATA[  </tr>       <tr>          <td width="546"><font face="Verdana" size="2">Volumen minuto</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>          <td width="546"><font face="Verdana" size="2">Frecuencia respiratoria</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>          <td width="546"><font face="Verdana" size="2">FiO2 (fracci&oacute;n de ox&iacute;geno            en el aire inspirado)</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>     ]]></body>
<body><![CDATA[  <tr>          <td width="546"><font face="Verdana" size="2">Presi&oacute;n pico</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>          <td width="546"><font face="Verdana" size="2">Presi&oacute;n pausa</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>          <td width="546"><font face="Verdana" size="2">Presi&oacute;n positiva al final            de la espiraci&oacute;n (P.e.e.p por sus siglas en ingl&eacute;s)</font></td>         <td width="28"><font face="Verdana" size="2"></font></td>         <td width="25"><font face="Verdana" size="2"></font></td>         <td width="23"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>     ]]></body>
<body><![CDATA[    <td width="18"><font face="Verdana" size="2"></font></td>         <td width="15"><font face="Verdana" size="2"></font></td>         <td width="20"><font face="Verdana" size="2"></font></td>         <td width="17"><font face="Verdana" size="2"></font></td>         <td width="16"><font face="Verdana" size="2"></font></td>         <td width="21"><font face="Verdana" size="2"></font></td>         <td width="19"><font face="Verdana" size="2"></font></td>         <td width="22"><font size="2" face="Verdana"></font></td>       </tr>       <tr>      ]]></body>
<body><![CDATA[    <td width="546"><font face="Verdana" size="2">Auto-peep    <br>       (Peep intr&iacute;nseca)    <br>       </font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22"><font size="2" face="Verdana"></font></td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">Presi&oacute;n AW (Presi&oacute;n        en v&iacute;as a&eacute;reas)</font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22"><font size="2" face="Verdana"></font></td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">R. I / E (relaci&oacute;n inspiraci&oacute;n        / espiraci&oacute;n)</font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22"><font size="2" face="Verdana"></font></td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">Flujo inspiratorio</font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22"><font size="2" face="Verdana"></font></td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">Tiempo inspiratorio</font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22"><font size="2" face="Verdana"></font></td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">Cl. est&aacute;tica    <br>       (compliance: adaptabilidad est&aacute;tica)     <br>       </font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22">&nbsp;</td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">PaO2 / FiO2 (relaci&oacute;n        presi&oacute;n arterial de ox&iacute;geno / fracci&oacute;n de ox&iacute;geno        en el aire inspirado)</font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22">&nbsp;</td>   </tr>   <tr>      <td width="546"><font face="Verdana" size="2">Gasometr&iacute;a</font></td>     <td width="28"><font face="Verdana" size="2"></font></td>     <td width="25"><font face="Verdana" size="2"></font></td>     <td width="23"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="18"><font face="Verdana" size="2"></font></td>     <td width="15"><font face="Verdana" size="2"></font></td>     <td width="20"><font face="Verdana" size="2"></font></td>     <td width="17"><font face="Verdana" size="2"></font></td>     <td width="16"><font face="Verdana" size="2"></font></td>     <td width="21"><font face="Verdana" size="2"></font></td>     <td width="19"><font face="Verdana" size="2"></font></td>     <td width="22">&nbsp;</td>   </tr> </table>     <P><font face="Verdana" size="2">Rx T&oacute;rax____________________ </font>     <P><font face="Verdana" size="2">Complicaci&oacute;n____________________ </font>     <P><font face="Verdana" size="2">25. Cirug&iacute;a: </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Hecho en____________________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Fecha_______________    </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Operaci&oacute;n    realizada__________________ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Complicaciones:    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-    Transoperatoria________ Posoperatoria_________ </font>      <P><font face="Verdana" size="2"> 26. Reintervenciones : </font>     <P><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Lugar: ______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Fecha ______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Causa______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Correlaci&oacute;n:    S&iacute;____ No_____ </font>     <P><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) Complicaciones___________________________    </font>     <P><font face="Verdana" size="2">27. Interrupci&oacute;n del embarazo: S&iacute;____    No____ </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) T&eacute;cnica_____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Causa_____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Lugar_____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Fecha_____________    </font>     <P><font face="Verdana" size="2">28. Otra maniobra invasiva: S&iacute;____ No____    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Tipo______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Fecha______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Lugar______________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Causa______________    </font>     <P><font face="Verdana" size="2">29. Alimentaci&oacute;n: </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Oral _____ Enteral    _____ Parenteral _____ Ninguna_____ Fecha &#151;&#151;-&#151;&#151;&#151;&#151;&#151;&#151;.    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Complicaciones    _________________________ </font>     <P><font face="Verdana" size="2">30. Complicaciones en U.T.I.: </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Tipo_____ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Fecha_____ </font>     <P><font face="Verdana" size="2">31. Terap&eacute;utica: </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Antes de U.T.I_______    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) En U.T.I____________    </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Medicamento    y dosis___________ </font>     <P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Tiempo de uso_________________    </font>     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) Reacci&oacute;n    adversa_________________ </font>     <P><font face="Verdana" size="2">32. Diagn&oacute;stico final____________________    </font>     <P><font face="Verdana" size="2">33. Fallecida ____Viva _____ Necropsia ______    </font>     <P><font face="Verdana" size="2">34. Comentario. </font>     <P>    <br>     <P>      <P><font face="Verdana" size="2"><a name="ane2"></a><B>Anexo 2</B>.<B> </B>Criterios    de<B> </B>disfunci&oacute;n / fallo de &oacute;rganos.     <br>       <br>   </font>  <table class=MsoTableWeb1 border=1 cellspacing=3 cellpadding=0 width=671  style='width:503.25pt;mso-cellspacing:2.0pt;mso-yfti-tbllook:160;mso-padding-alt:  0cm 5.4pt 0cm 5.4pt;mso-border-insideh:.75pt outset windowtext;mso-border-insidev:  .75pt outset windowtext' align="center">   <tr style='mso-yfti-irow:-1;mso-yfti-firstrow:yes'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt'>            ]]></body>
<body><![CDATA[<p class=MsoNormal style='text-align:justify;mso-yfti-cnfc:1'><font face="Verdana" size="2"><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Sistema <o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt'>            <p class=MsoNormal style='text-align:justify;mso-yfti-cnfc:1' align="center"><font face="Verdana" size="2"><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disfunción<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt'>            <p class=MsoNormal style='text-align:justify;mso-yfti-cnfc:1'><font face="Verdana" size="2"><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fallo<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:0'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="102">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Cardiovascular<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="102">            <p class=PrrafodelistaCxSpFirst style='margin-left:0cm;mso-add-space:auto;   text-align:justify;text-indent:0cm;mso-list:l1 level1 lfo1;tab-stops:11.9pt'><font face="Verdana" size="2"><span   lang=ES style='font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:   Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span   style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>          <span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>TAM &lt; 70 mmHg.<o:p>    <br>         </o:p></span><span   lang=ES style='font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:   Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span   style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span><span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>necesidades de volumen<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="102">            <p class=PrrafodelistaCxSpMiddle style='margin-left:9.6pt;mso-add-space:auto;   text-align:justify;text-indent:-7.1pt;mso-list:l1 level1 lfo1'><font face="Verdana" size="2"><span   lang=ES style='font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:   Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span   style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span> <span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>TAM &lt; 50 mmHg    <br>         </span><span   lang=ES style='font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:   Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span   style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span> <span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>Necesidad de inotrópicos<o:p>    <br>         </o:p></span><span   lang=ES style='font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:   Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span   style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span> <span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>Frecuencia cardiaca &lt; 50 o mayor &nbsp;&nbsp;de 120 / min.<o:p>    <br>         </o:p></span><span   lang=ES style='font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:   Symbol;mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span   style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;</span></span></span><span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>Arritmia supra-ventriculares o</span> <span   lang=ES style='font-size:10.0pt;font-family:Verdana;mso-bidi-font-family:   Arial'>&nbsp; &nbsp;&nbsp;ambas, de difícil control<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:1;height:74.1pt'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt;   height:74.1pt' height="105">            ]]></body>
<body><![CDATA[<p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Respiratorio<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt;   height:74.1pt' height="105">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l8 level1 lfo2;tab-stops:10.45pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Frecuencia &gt; 28 / min.<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>PaO<sub>2</sub>/<span class=SpellE>FiO<sub>2</sub></span>          de 200- 300 mmHg<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>DA-<span class=SpellE>aO<sub>2</sub></span> &gt;          250 mmHg<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Necesidad de VMA<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt;   height:74.1pt' height="105">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l8 level1 lfo2;tab-stops:10.4pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Frecuencia &gt; 40 o &lt; 5 min<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'><span style='mso-spacerun:yes'> </span>PaO<sub>2</sub>          /<span class=SpellE>FiO<sub>2</sub></span> &lt; 200 mmHg<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'><o:p></o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span><span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'><span style='mso-spacerun:yes'> </span>DA-<span   class=SpellE>aO<sub>2</sub></span> &gt; 350 mmHg<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'><span style='mso-spacerun:yes'> </span>Necesidad          de <span class=SpellE>F<sub>i</sub>O<sub>2</sub></span> &gt; 40 %<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Peep</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> &gt; 10 <span   class=SpellE>cmH20    ]]></body>
<body><![CDATA[<br>         </span><o:p></o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'><o:p></o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>PaCO2</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> &gt; 50 mmHg<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:2'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="70">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Renal<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="70">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l0 level1 lfo3;tab-stops:8.2pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Creatinina</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> sérica &gt;2mg/<span class=SpellE>dl</span><o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>&nbsp;&nbsp;( 176 <span class=SpellE>mmol</span>/l)<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="70">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l0 level1 lfo3;tab-stops:11.15pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Diuresis &lt; 0,5 <span class=SpellE>ml</span>/<span   class=SpellE>kg</span>/hora<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>BUN &gt; 100 <span class=SpellE>mg</span>/dl<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Creatinina</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> sérica&gt;3,5          <span class=SpellE>mg</span>/<span class=SpellE>dl</span><o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Necesidad de diálisis.<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:3'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="104">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Sangre<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="104">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l4 level1 lfo4;tab-stops:9.7pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Recuento <span class=SpellE>linfocitario</span>          total menor &nbsp;&nbsp;&nbsp;de 2,000 / <span class=SpellE>mm</span>          <sup>3</sup><o:p>    ]]></body>
<body><![CDATA[<br>         </o:p></span></font><font face="Verdana" size="2"><span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'><o:p></o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Plaquetas &lt; 80000 / <span class=SpellE>mm</span>          <sup>3</sup><o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="104">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l4 level1 lfo4;tab-stops:11.15pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Leucocitos&lt; 3000 o &gt;30000/mm<sup>3</sup><o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Recuento <span class=SpellE>linfocitario</span>          total menor &nbsp;&nbsp;&nbsp;&nbsp;de 1,200 / <span class=SpellE>mm</span>          <sup>3</sup>    <br>         </span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Plaquetas &lt; 30000/mm<sup>3 </sup>o<span   style='mso-spacerun:yes'>           </span>&nbsp;&nbsp;&nbsp;&lt; 50000/mm<sup>3</sup>          con sangrado activo<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>TP o TPT<span style='mso-spacerun:yes'>  </span>&gt;          25 %<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:4'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="104">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Hígado<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="104">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l3 level1 lfo5;tab-stops:11.95pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Bilirrubina&gt;3mg/<span class=SpellE>dl</span>          (34,3mmol/l)<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>TGP y LDH &lt; 2 veces lo normal<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>TP + de 4 <span class=SpellE>seg</span> el control.<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Albúmina sérica &lt; 30g/l<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="104">            ]]></body>
<body><![CDATA[<p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l3 level1 lfo5;tab-stops:8.15pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Bilirrubina&gt; 6mg/<span class=SpellE>dl</span>          (102,6 <span class=SpellE>mmol</span>/l)<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>TGP y LDH &gt; 2 veces lo normal<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>TP + de 1,5 veces el control<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Fibrinógeno</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> &lt;150 <span   class=SpellE>mg</span>/<span class=SpellE>dl</span><o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>PDF positivo.<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Albúmina sérica &lt; 25g/l<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:5'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="55">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Digestivo<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="55">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l2 level1 lfo7;tab-stops:11.95pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Íleo médico &gt; 48 h<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Íleo quirúrgico &gt; 96 h<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Intolerancia vía <span class=SpellE>enteral</span><o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="55">            ]]></body>
<body><![CDATA[<p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l2 level1 lfo7;tab-stops:9.65pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Hemorragia digestiva<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Colecistitis <span class=SpellE>alitiásica</span><o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Pancreatitis aguda<o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:6'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="36">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Sistema nervioso central (SNC)<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="36">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l6 level1 lfo8;tab-stops:11.95pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Coma Glasgow 8 - 11<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="36">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l6 level1 lfo8;tab-stops:9.65pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Coma Glasgow &lt; 8 <o:p></o:p></span></font></p>     </td>   </tr>   <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>      <td width=132 valign=top style='width:99.25pt;padding:0cm 5.4pt 0cm 5.4pt' height="88">            <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>Metabólico /</span></font></p>           <p class=MsoNormal style='text-align:justify'><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'> Nutricional<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="88">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l5 level1 lfo9;tab-stops:11.95pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>pH</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> 7,30–7,24 y          <span   class=SpellE>PaCO<sub>2</sub></span> 40 mmHg<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Na</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> entre 125 y          130 o entre<o:p>    ]]></body>
<body><![CDATA[<br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'><o:p></o:p></span></font><font face="Verdana" size="2"><span lang=ES style='font-family:   Verdana;mso-bidi-font-family:Arial'>&nbsp;&nbsp;&nbsp;150 y 160 <span class=SpellE>mEq</span>/l<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>K entre 2,5-3 o 5,5-6 <span class=SpellE>mEq</span>/l<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Glucosa &gt; 250 <span class=SpellE>mg</span>/dl.<o:p></o:p></span></font></p>     </td>     <td width=269 valign=top style='width:202.0pt;padding:0cm 5.4pt 0cm 5.4pt' height="88">            <p class=MsoNormal style='margin-left:0cm;text-align:justify;text-indent:   0cm;mso-list:l5 level1 lfo9;tab-stops:9.65pt'><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>pH</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> &lt; <st1:time   Minute="24" Hour="7" w:st="on">7,24</st1:time> con PCO<sub>2</sub><span   style='mso-spacerun:yes'>  </span>40 mmHg<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span class=SpellE><span lang=ES   style='font-family:Verdana;mso-bidi-font-family:Arial'>Na</span></span><span   lang=ES style='font-family:Verdana;mso-bidi-font-family:Arial'> &lt; 130 o &gt;160          <span class=SpellE>mEq</span>/l<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>K &lt; 2,5 o &gt; 6 <span class=SpellE>mEq</span>/l<o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Glucosa &lt; 40 o &gt;500mg/<span class=SpellE>dl</span><o:p>    <br>         </o:p></span></font><font face="Verdana" size="2"><span   lang=ES style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:   Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;          </span></span></span> <span lang=ES style='font-family:Verdana;   mso-bidi-font-family:Arial'>Proteína total &lt; 60mEq/l<o:p></o:p></span></font></p>     </td>   </tr> </table>     <p align="center"><font size="2" face="Verdana">Fuente: E. B&eacute;cquer Garc&iacute;a.    S&iacute;ndrome de disfunci&oacute;n m&uacute;ltiple de &oacute;rganos. En:    Terapia Intensiva    <br>   Tomo IV/Armando Caballero L&oacute;pez (et al). 2da. ed. La Habana: Editorial    Ciencias M&eacute;dicas; 2009.</font></p>     ]]></body>
<body><![CDATA[<p align="center">&nbsp;</p>     <P>      <P>      <P>      <P><font face="Verdana" size="2"><B><font size="3">REFERENCIAS BIBLIOGR&Aacute;FICAS</font></B>    </font>      <!-- ref --><P><font face="Verdana" size="2">1. Cunningham GF, Gant FN. Medical and surgical    complications in pregnancy. Renal and urinary tract disorders Section 12 Chapter    47. En: Cunningham GF, editor. Williams Obstetrics. (Windows-CD-Rom); 21st.ed.    Stamford USA: Mc Graw - Hill Professional; 2001. p. 540.     </font>      <P>      <!-- ref --><P><font face="Verdana" size="2">2. Krane NK. Acute renal failure in pregnancy.    Arch Intern Med. 1988;148:2347.     </font>     ]]></body>
<body><![CDATA[<P>      <!-- ref --><P><font face="Verdana" size="2">3. Abernethy VE, Lieberthal W. Acute renal failure    in the critically ill patient. Crit Care Clin. 2002;18:203-22.     </font>     <P>      <!-- ref --><P><font face="Verdana" size="2">4. Albright RC. Acute renal failure: a practical    update. Mayo Clin Proc. 2001;76:67-74.     </font>      <P>      <!-- ref --><P><font face="Verdana" size="2">5. Singri N, Ahya SN, Levin ML. Acute renal failure.    JAMA. 2003;289:747-51.     </font>     <P>      ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana" size="2">6. Mehta RL, Kellum JA, Shah SV, Molitoris BA,    Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an iniciative    to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31-R40.     </font>     <P>      <!-- ref --><P><font face="Verdana" size="2">7. Chertow GM, Christiansen CL, Cleary PD, Munro    C, Lazarus JM. Prognostic stratification in critically ill patients with acute    renal failure requiring dialysis. Arch Intern Med. 1995;155:1505-11.     </font>     <P>      <!-- ref --><P><font face="Verdana" size="2">8. S&aacute;nchez Valdivia A, S&aacute;nchez    Padr&oacute;n A. Distr&eacute;s respiratorio agudo en el embarazo. Rev Cubana    Obstet Ginecol. 2006;32(1).     </font>      <P>      <!-- ref --><P><font face="Verdana" size="2">9. S&aacute;nchez Padr&oacute;n A, S&aacute;nchez    Valdivia A, Fern&aacute;ndez Mor&iacute;n J. Distr&eacute;s respiratorio agudo    y embarazo: algunos aspectos de inter&eacute;s. Rev Cubana Obstet Ginecol. 2006;32(3).        </font>      <P>      <!-- ref --><P><font face="Verdana" size="2">10. S&aacute;nchez Valdivia A. Morbimortalidad    materna. Algunos aspectos cl&iacute;nicos y epidemiol&oacute;gicos [trabajo    de terminaci&oacute;n de Residencia Medicina Interna]. Hospital Universitario    &quot;Faustino P&eacute;rez&quot;. Facultad de Ciencias M&eacute;dicas de Matanzas:    Universidad de La Habana; 2001.     </font>      <P>      <!-- ref --><P><font face="Verdana" size="2">11. de Mendonca A, Vincent JL, Suter PM, Moreno    R, Dearden NM, Antonelli M, et al. Acute renal failure in ICU: risk factors    and outcomes evaluated by the SOFA score. Intensive Care Med. 2000;26:915-21.        </font>     <P>      <!-- ref --><P><font face="Verdana" size="2">12. Guerin C, Girard R, Selli JM, Perdrix JP,    Ayzac L. Initial versus Delayed Acute Renal Failure in the Intensive Care Unit.    A Multicenter Prospective Epidemiological Study. Am J Respir Crit Care Med.    2000;161:872-9.     </font>     ]]></body>
<body><![CDATA[<P>      <!-- ref --><P><font face="Verdana" size="2">13. Schrier RW, Wang W, Poole B, Mitra A. Acute    renal failure: definitions, diagnosis, pathogenesis and therapy. J Clin Invest.    2004;114:5-14.     </font>      <P>      <!-- ref --><P><font face="Verdana" size="2">14. Teehan GS. Dialysis membrane and modality    in acute renal failure: understanding discordant meta-analyses. Semin Dial.    2003;16:356-60.     </font>     <P>      <!-- ref --><P><font face="Verdana" size="2">15. Murray P, Hall J. Renal replacement therapy    for acute renal failure. Am J Respir Crit Care Med. 2000;162:777-81.     </font>     <P>      ]]></body>
<body><![CDATA[<!-- ref --><P><font face="Verdana" size="2">16. Ronco C, Bellomo R, Ricci Z. Continuous renal    replacement therapy in critically ill patients. Nephrol Dial Transplant. 2001;16(5):67-72.        </font>      <P>     <P>      <P>      <P>      <P><font face="Verdana" size="2">Recibido: 30 de junio de 2011.     <br> </font><font face="Verdana" size="2">Aprobado: 15 de julio de 2011. </font>     <P>     <P>      ]]></body>
<body><![CDATA[<P>      <P>      <P><font face="Verdana" size="2"><I>Alfredo Jorge S&aacute;nchez Valdivia.</I>    Hospital Universitario &quot;Faustino P&eacute;rez&quot;. Carretera Central    km 101. Matanzas, Cuba. Correo electr&oacute;nico: <a href="mailto:alfredosanchez.mtz@infomed.sld.cu">alfredosanchez.mtz@infomed.sld.cu</a></font>       ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
<name>
<surname><![CDATA[Gant]]></surname>
<given-names><![CDATA[FN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Medical and surgical complications in pregnancy. Renal and urinary tract disorders Section 12 Chapter 47]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
</person-group>
<source><![CDATA[Williams Obstetrics]]></source>
<year>2001</year>
<edition>21</edition>
<page-range>540</page-range><publisher-loc><![CDATA[Stamford^eUSA USA]]></publisher-loc>
<publisher-name><![CDATA[Mc Graw - Hill Professional]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krane]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute renal failure in pregnancy]]></article-title>
<source><![CDATA[Arch Intern Med.]]></source>
<year>1988</year>
<volume>148</volume>
<page-range>2347</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abernethy]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
<name>
<surname><![CDATA[Lieberthal]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute renal failure in the critically ill patient]]></article-title>
<source><![CDATA[Crit Care Clin.]]></source>
<year>2002</year>
<volume>18</volume>
<page-range>203-22</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albright]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute renal failure: a practical update]]></article-title>
<source><![CDATA[Mayo Clin Proc.]]></source>
<year>2001</year>
<volume>76</volume>
<page-range>67-74</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singri]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ahya]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Levin]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute renal failure]]></article-title>
<source><![CDATA[JAMA.]]></source>
<year>2003</year>
<volume>289</volume>
<page-range>747-51</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
<name>
<surname><![CDATA[Molitoris]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Warnock]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[et]]></surname>
<given-names><![CDATA[al]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute Kidney Injury Network: report of an iniciative to improve outcomes in acute kidney injury]]></article-title>
<source><![CDATA[Crit Care.]]></source>
<year>2007</year>
<volume>11</volume>
<page-range>R31-R40</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chertow]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Christiansen]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Cleary]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Munro]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lazarus]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prognostic stratification in critically ill patients with acute renal failure requiring dialysis]]></article-title>
<source><![CDATA[Arch Intern Med.]]></source>
<year>1995</year>
<volume>155</volume>
<page-range>1505-11</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Valdivia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Padrón]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Distrés respiratorio agudo en el embarazo]]></article-title>
<source><![CDATA[Rev Cubana Obstet Ginecol.]]></source>
<year>2006</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Padrón]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Valdivia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Morín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Distrés respiratorio agudo y embarazo: algunos aspectos de interés]]></article-title>
<source><![CDATA[Rev Cubana Obstet Ginecol.]]></source>
<year>2006</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Valdivia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Morbimortalidad materna. Algunos aspectos clínicos y epidemiológicos]]></source>
<year>2001</year>
<conf-name><![CDATA[ trabajo de terminación de Residencia Medicina Interna]]></conf-name>
<conf-loc> </conf-loc>
<publisher-name><![CDATA[Universidad de La Habana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Mendonca]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Suter]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dearden]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Antonelli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute renal failure in ICU: risk factors and outcomes evaluated by the SOFA score]]></article-title>
<source><![CDATA[Intensive Care Med.]]></source>
<year>2000</year>
<volume>26</volume>
<page-range>915-21</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Girard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Selli]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Perdrix]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Ayzac]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Initial versus Delayed Acute Renal Failure in the Intensive Care Unit. A Multicenter Prospective Epidemiological Study]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2000</year>
<volume>161</volume>
<page-range>872-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schrier]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Poole]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mitra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acute renal failure: definitions, diagnosis, pathogenesis and therapy]]></article-title>
<source><![CDATA[J Clin Invest.]]></source>
<year>2004</year>
<volume>114</volume>
<page-range>5-14</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Teehan]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Dialysis membrane and modality in acute renal failure: understanding discordant meta-analyses]]></article-title>
<source><![CDATA[Semin Dial.]]></source>
<year>2003</year>
<volume>16</volume>
<page-range>356-60</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Renal replacement therapy for acute renal failure]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2000</year>
<volume>162</volume>
<page-range>777-81</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bellomo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ricci]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Continuous renal replacement therapy in critically ill patients]]></article-title>
<source><![CDATA[Nephrol Dial Transplant.]]></source>
<year>2001</year>
<volume>16</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>67-72</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
